Quality Control  
  Our New Products  
  Our Contacts  
  Office :-  
  328-329, Paradise Complex
Sayajigunj, Baroda 390 005,
91-265-2362319 / 2362966, 6641924, 6457170
91 - 265 - 2226 093
  Reg. Office :-  
Kika Street
Gulabvadi Mumbai-400004
  Factory :-  
  Plot No.165/P
At. Vadadala
Tal. Savli, Dist Baroda 391520
91 - 2667 - 2510522

“The Indian pharmaceutical industry is at the center stage in the global pharmaceutical arena and Rekvina is at the forefront in delivering the India centric advantages to the advanced and developing countries of the world.
From a small domestic company at inception in late 90’s, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of twenty crore INR.

It is with the unwavering ' dedication ' and the ' will to win ' of Team Rekvina across India that we have traversed this journey so far.

We are committed to provide quality medication at affordable prices to the patients with a view to help bring down the healthcare costs. We are confident that our efforts would see the Company grow from strength to strength in the global space in the years to come. Whilst we continue to enhance the momentum of our products, we are also accelerating our drug discovery program through collaborations and alliances .

As we move ahead we are determined to capitalize on the new opportunities based on our strong fundamentals of innovation, entrepreneurship and aggressive marketing. We remain committed to actively pursue our strategy of growth through organic and inorganic means.

Today, we are amongst the Top 100 fastest growing companies; we are well placed to realize our aspirations of being amongst the top 100 pharmaceuticals companies and attain a size of  100 crore INR by 2012. As we step into the next phase, we are driven by our ambition, willing to invest in the growth of our people and business, marching towards the new horizon of global leadership."

Mr. Mukesh Shah
Chairman & Managing Director

   © Copyright 2008 Rekvina ® All Rights Reserved.